Skip to content

The Effectiveness of Patient Navigation in Cancer Care

The Effectiveness of Patient Navigation in Cancer Care

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03305965
Enrollment
120
Registered
2017-10-10
Start date
2016-10-15
Completion date
2018-06-01
Last updated
2017-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Brief summary

Rationale: Supportive care such as physical therapy, psycho-social education, and dietary advice is likely to have a positive effect on the recovery and quality of life of cancer patients. Currently, not all patients know how to access supportive care, which results in unmet supportive care needs. This study determines whether these unmet needs can be reduced or prevented by a patient navigation intervention that focuses on timely screening and systematic monitoring of patient's supportive care needs. Objective: The primary objective is to determine the effect of patient navigation on health related quality of life. Secondary objectives are: 1) to determine the effect of patient navigation on satisfaction with, need for, and consumption of (supportive) cancer care; 2) to determine the effect of patient navigation on patients' self-management; 3) to explore how patient navigation affects the cost-effectiveness of cancer care. Study design: Longitudinal randomised controlled trial with two study arms: a patient navigation intervention and care as usual. Study population: Newly diagnosed lung, melanoma, urology, or gynecology patients of the Netherlands Cancer Institute. Intervention : Consultations with a specifically trained oncology nurse (i.e. patient navigator), who assesses patients' needs for supportive cancer care, provides information on supportive cancer care, and guides patients through the supportive cancer care system. Consultations with the patient navigator take place at the start, halfway through, and at the end of treatment. Main study endpoints: The main endpoint of this study is health related quality of life, which is defined as an individual's perceived emotional, social, physical, and functional wellbeing over time. Health related quality of life is assessed with the EORTC QLQ-C30. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Participants are expected to strongly benefit from consulting the patient navigator without being subjected to any severe risks. Consultations will be provided by highly qualified professionals, and result in benefits such as decreased severity of cancer-related psychosocial and physical distress. To minimise burden, face-to-face consultations will always be scheduled alongside other appointments of at the NKI-AVL. Furthermore, questionnaire completion takes no more than 30 minutes per data collection round, of which three are scheduled in this study.

Interventions

BEHAVIORALPatient navigation

Consultations with a specifically trained oncology nurse (i.e. patient navigator), who assesses patients' needs for supportive cancer care, provides information on supportive cancer care, and guides patients through the supportive cancer care system. Consultations with the patient navigator take place at the start, halfway through, and at the end of treatment.

Sponsors

The Netherlands Cancer Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Patient navigation vs. care as usual

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosed with lung, melanoma, urology or gynecology related cancer * Male or female * Treated at the Dutch Cancer Institute * Has not started treatment at the Dutch Cancer Institute * 18 years of age and over * Curative or palliative treatment * Able to understands and speak Dutch

Exclusion criteria

* Not willing to sign the consent form * Not willing to meet with the patient navigator * Not willing to complete questionnaires at any point in time

Design outcomes

Primary

MeasureTime frameDescription
Change in health related quality of lifeBaseline, month 1, month 3, month 5EORTC QLQ-C30

Secondary

MeasureTime frameDescription
Satisfaction with (supportive) cancer careMonth 5(Adapted version of) Patient Satisfaction with Cancer Care
Change in consumption of supportive cancer careBaseline, month 1, month 3, month 5(Adapted version of) Medical Consumption Questionnaire
Change in need for supportive cancer careBaseline, month 1, month 3, month 5Distress Thermometer
Change in work productivityBaseline and month 5Study specific questions on work productivity
Change in health statusBaseline and month 5EQ-5D-5L
Change in self-managementBaseline, month 1, month 3, month 5Study specific questions on knowledge and self-efficacy

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026